Dynamic Changes in Fasting Blood Glucose Levels During Hospitalization and at Discharge Among Pediatric Patients with COVID-19: A Retrospective Cohort Study in Southwest Iran
This retrospective cohort study of 600 non-diabetic pediatric patients in Southwest Iran reveals that fasting blood glucose levels significantly increase from admission to discharge during COVID-19 hospitalization, with these fluctuations notably influenced by age and underlying comorbidities but not by sex, disease severity, or length of stay.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a virus enters the body, it does not just attack the lungs; it sends ripples through the entire system, often disrupting the delicate machinery that keeps our blood sugar in balance. In adults, this disruption is well known: a severe infection can cause blood sugar to spike dangerously high, a state often called stress hyperglycemia, which can complicate recovery and even lead to new cases of diabetes. For years, doctors assumed children were largely immune to these metabolic storms, viewing them as a group that typically recovers from respiratory infections with fewer systemic side effects. However, as the global pandemic unfolded, scientists began to wonder if the virus was quietly altering the chemistry of young bodies in ways that were not immediately obvious. The question was not just whether children got sick, but whether the virus left a lingering mark on their ability to regulate glucose, the primary fuel their cells use to function, even after the fever broke and the breathing improved.
A team of researchers in Southwest Iran set out to investigate this specific mystery by looking at the blood sugar levels of children hospitalized with the virus. They focused on a group of 600 patients, all under the age of 18, who had been admitted to a major pediatric hospital in Ahvaz between 2021 and 2022. Crucially, the researchers excluded any child who already had a history of diabetes, ensuring that they were observing changes caused solely by the infection rather than pre-existing conditions. The team tracked two specific moments for every child: the first time their blood sugar was measured upon arrival at the hospital, and the final measurement taken just before they were discharged home. By comparing these two points, the researchers could see how the body's sugar levels shifted during the course of the illness and the subsequent recovery period.
The results revealed a pattern that challenges the assumption that children are metabolically unaffected by the virus. The study found that, on average, the children's fasting blood sugar levels were higher when they left the hospital than when they arrived. At admission, the average level was 85.68 milligrams per deciliter, but by the time of discharge, that average had risen to 92.86 milligrams per deciliter. This increase was statistically significant, meaning it was unlikely to be a random fluctuation. The data suggests that the metabolic stress triggered by the infection does not necessarily resolve as quickly as the respiratory symptoms do. Instead, the body may remain in a state of elevated blood sugar throughout the hospital stay, potentially indicating that the virus or the body's immune response to it continues to strain the pancreas or the liver even as the child begins to feel better.
The researchers also looked for clues about which children were most likely to experience these changes. They found that the presence of other underlying health conditions made a clear difference. Children who had pre-existing medical issues, such as cerebral palsy or genetic disorders, showed significantly different blood sugar patterns compared to their healthier peers. These children with comorbidities maintained higher glucose levels throughout their stay, suggesting that a body already under stress is less able to handle the additional metabolic hit of a viral infection. In contrast, the study found that other factors did not seem to drive these changes. The sex of the child, whether they lived in a city or the countryside, and how severe their breathing difficulties were did not predict whether their blood sugar would rise. Even the length of time a child spent in the hospital did not correlate with the size of the increase, indicating that the metabolic shift is a consistent feature of the recovery phase rather than a result of prolonged exposure to hospital care.
One of the more subtle findings involved the age of the children. The researchers observed a weak but measurable link between age and blood sugar levels at the moment of admission, with older children tending to have slightly higher initial readings. This aligns with the understanding that the body's stress response, which involves the release of hormones like cortisol to fight infection, matures as a child grows. However, this age factor did not explain the rise in sugar levels by the time of discharge, nor did it predict the magnitude of the change. The study also noted that the average length of stay for these children was just under six days, yet the metabolic disturbance persisted through that entire window.
These findings point toward a biological reality where the virus may be causing a temporary but significant disruption to how children process sugar. The researchers suggest that the virus might be directly affecting the cells in the pancreas that produce insulin, or it could be stimulating the liver to release more glucose into the bloodstream as part of the immune response. Because the study was retrospective, meaning it looked back at existing medical records, the team could not measure specific markers of insulin production or resistance during the illness. They also could not account for the potential effects of medications like corticosteroids, which are sometimes used to treat severe cases and are known to raise blood sugar. Despite these limitations, the data provides a clear signal that the metabolic impact of the virus in children is not always fleeting.
The implications of this research extend beyond the hospital walls. The fact that blood sugar levels were still elevated at the time of discharge suggests that the recovery from the infection is not just about clearing the virus from the lungs, but also about allowing the body's metabolic systems to return to normal. The researchers propose that children, particularly those with other health conditions, might benefit from follow-up checks for blood sugar after they leave the hospital. This would ensure that any lingering dysregulation is caught early, preventing potential long-term issues. The study does not claim that every child will develop diabetes, but it does highlight that the virus can leave a metabolic footprint that lasts longer than the acute phase of the illness, urging doctors and parents to remain vigilant about the metabolic health of children even after they have recovered from the respiratory symptoms.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.